{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:49:10Z","timestamp":1785149350593,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013227","name":"Health Promotion Administration, Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jfma.2025.09.016","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:18:13Z","timestamp":1757769493000},"page":"S102-S108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S2","title":["Nationwide hepatitis C virus microelimination in uremic patients undergoing maintenance hemodialysis in Taiwan"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3367-068X","authenticated-orcid":false,"given":"Chung-Feng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Cheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ju","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Chun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Lun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7489-7217","authenticated-orcid":false,"given":"Li-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chun","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsui-Hsia","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie Shu-Mei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Xin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4202-6041","authenticated-orcid":false,"given":"Tsu-Yun","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Hsuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Pen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8145-1900","authenticated-orcid":false,"given":"Ming-Lung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2025.09.016_bib1","series-title":"Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis","year":"2016"},{"key":"10.1016\/j.jfma.2025.09.016_bib2","unstructured":"World Health Organiztion Interim guidance for country validation of viral hepatitis elimination. https:\/\/wwwwhoint\/publications\/i\/item\/9789240028395 Accessed on 2025\/04\/10.."},{"issue":"2","key":"10.1016\/j.jfma.2025.09.016_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2025.01.013","article-title":"Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies","volume":"83","author":"Razavi","year":"2025","journal-title":"J Hepatol (Amst)"},{"issue":"6","key":"10.1016\/j.jfma.2025.09.016_bib4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/apt.15131","article-title":"Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East Asia","volume":"49","author":"Younossi","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.jfma.2025.09.016_bib5","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1046\/j.1440-1746.2000.02195.x","article-title":"Serotyping and genotyping of hepatitis C virus in Taiwanese patients with type C chronic liver disease and uraemic patients on maintenance haemodialysis","volume":"15","author":"Yu","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.jfma.2025.09.016_bib6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5301\/ijao.5000437","article-title":"Transmission of hepatitis C virus in dialysis units: a systematic review of reports on outbreaks","volume":"38","author":"Fabrizi","year":"2015","journal-title":"Int J Artif Organs"},{"issue":"2","key":"10.1016\/j.jfma.2025.09.016_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jhep.2013.09.023","article-title":"High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients","volume":"60","author":"Yu","year":"2014","journal-title":"J Hepatol (Amst)"},{"issue":"2","key":"10.1016\/j.jfma.2025.09.016_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1440-1746.2010.06488.x","article-title":"Treatment of hepatitis C virus infection in patients with end-stage renal disease","volume":"26","author":"Liu","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jfma.2025.09.016_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/jvh.13477","article-title":"Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group","volume":"28","author":"Wei","year":"2021","journal-title":"J Viral Hepat"},{"issue":"Suppl 3","key":"10.1016\/j.jfma.2025.09.016_bib10","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1093\/infdis\/jiac446","article-title":"HCV microelimination for high-risk special populations","volume":"228","author":"Huang","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jfma.2025.09.016_bib11","unstructured":"NIDDK. USRDS. https:\/\/usrds-adr.niddk.nih.gov\/2023\/end-stage-renal-disease\/11-international-comparisons. Accessed on 2025\/05\/10.."},{"issue":"2","key":"10.1016\/j.jfma.2025.09.016_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000049035","article-title":"Epidemiology and clinical significance of chronic hepatitis-related viruses infection in hemodialysis patients from Taiwan","volume":"90","author":"Dai","year":"2002","journal-title":"Nephron"},{"issue":"12","key":"10.1016\/j.jfma.2025.09.016_bib13","first-page":"2429","article-title":"Therapy as prevention toward HCV elimination in maintenance hemodialysis: a multi-center, prospective cohort study","volume":"16","author":"Huang","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jfma.2025.09.016_bib14","unstructured":"https:\/\/www.tsn.org.tw\/en\/twrds.html. available on 2025\/04\/06.."},{"issue":"4","key":"10.1016\/j.jfma.2025.09.016_bib15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/apt.16697","article-title":"Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment","volume":"55","author":"Liu","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.jfma.2025.09.016_bib16","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1136\/gutjnl-2020-323277","article-title":"Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C)","volume":"70","author":"Yu","year":"2021","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jfma.2025.09.016_bib17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1053\/j.ajkd.2021.03.017","article-title":"Elimination of hepatitis C virus in a dialysis population: a collaborative care model in Taiwan","volume":"78","author":"Hu","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.jfma.2025.09.016_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000355615","article-title":"Hepatitis C infection is very rarely treated among hemodialysis patients","volume":"38","author":"Goodkin","year":"2013","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1016\/j.jfma.2025.09.016_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/gutjnl-2014-307080","article-title":"Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial","volume":"64","author":"Liu","year":"2015","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.jfma.2025.09.016_bib20","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jfma.2020.04.002","article-title":"Taiwan consensus statement on the management of hepatitis C: part (II) special populations","volume":"119","author":"Yu","year":"2020","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"10.1016\/j.jfma.2025.09.016_bib21","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jhep.2021.05.016","article-title":"Real-world experience of serial serum levels of GS-331007 in chronic hepatitis C hemodialysis patients during and after sofosbuvir\/velpatasvir therapy","volume":"75","author":"Huang","year":"2021","journal-title":"J Hepatol (Amst)"},{"issue":"1","key":"10.1016\/j.jfma.2025.09.016_bib22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3350\/cmh.2020.0180","article-title":"Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis","volume":"27","author":"Hsu","year":"2021","journal-title":"Clin Mol Hepatol"},{"issue":"11","key":"10.1016\/j.jfma.2025.09.016_bib23","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1111\/jgh.14672","article-title":"Paritaprevir\/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis","volume":"34","author":"Liu","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jfma.2025.09.016_bib24","doi-asserted-by":"crossref","first-page":"9180","DOI":"10.1038\/s41598-020-66182-8","article-title":"Elbasvir\/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jfma.2025.09.016_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3350\/cmh.2023.0287","article-title":"Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: a nationwide hepatitis C virus registry program","volume":"30","author":"Lu","year":"2024","journal-title":"Clin Mol Hepatol"},{"issue":"8","key":"10.1016\/j.jfma.2025.09.016_bib26","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ekir.2020.05.001","article-title":"Kidney Disease: improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline implementation: asia summit conference report","volume":"5","author":"Li","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1016\/j.jfma.2025.09.016_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s12072-019-09988-7","article-title":"APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation","volume":"13","author":"Kanda","year":"2019","journal-title":"Hepatol Int"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625004991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625004991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:57:56Z","timestamp":1766159876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664625004991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"alternative-id":["S0929664625004991"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2025.09.016","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nationwide hepatitis C virus microelimination in uremic patients undergoing maintenance hemodialysis in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2025.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}